OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
OpGen, Inc. (OPGN)
Last opgen, inc. earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.opgen.com
Company Research
Source: GlobeNewswire
Chinese regulatory authority NMPA completes registration of Unyvero instrument system as IVD for Chinese marketApplication of Unyvero cartridge for pneumonia is under review and pending NMPA approvalOpGen’s subsidiary Curetis and its Chinese partner Beijing Clear Biotech continue working with the NMPA towards approval of pneumonia test in China GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has recently received regulatory approval of the Curetis Unyvero System as an in vitro diagnostics (IVD) instrument system in China from the Chinese authorities (National Medical Products Administration, NMPA). The Medical Device Registration Certificate has been issued under the Registration number 20213220019. Since filing the submission dossier for the complete Unyvero System, consisting of the Uny
Show less
Read more
Impact Snapshot
Event Time:
OPGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OpGen, Inc. news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K [Yahoo! Finance]Yahoo! Finance
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KGlobeNewswire
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
OPGN
Earnings
- 11/14/23 - Miss
OPGN
Sec Filings
- 4/23/24 - Form 8-K
- 4/17/24 - Form 8-K
- 4/16/24 - Form PRE
- OPGN's page on the SEC website